← Open Payments lookup

ERIN STOCKMAN: Open Payments

NPI 1104218486 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$762 in 23 payments from 8 companies in 2025. Trend: 2023 $263 · 2024 $21 · 2025 $762

Food & beverage: $762
CompanyPaymentsAmount
GENZYME CORPORATION2$250
Novartis Pharmaceuticals Corporation12$210
Regeneron Healthcare Solutions, Inc.3$146
Takeda Pharmaceuticals U.S.A., Inc.2$53
Cycle Pharmaceuticals Inc1$32
Optinose US, Inc.1$28
Arcutis Biotherapeutics, Inc.1$26
AstraZeneca Pharmaceuticals LP1$17

Products named: DUPIXENT, Rhapsido, CUVITRU, Sajazir, Xhance, Zoryve, BREZTRI, XOLAIR.

Industry payments across CA — which companies pay providers there.